logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On June 16, CHINA LIT (00772) spent HK$12.54 million to repurchase 600,000 shares.

date
17:46 16/06/2026
avatar
GMT Eight
China Literature Group (00772) announced that the company repurchased 600,000 shares at a total cost of 12.5414 million Hong Kong dollars on June 16, 2026, with a repurchase price range of 20.62-21.04 Hong Kong dollars per share.
CHINA LIT (00772) announced that the company repurchased 600,000 shares at a price of HK$20.62-21.04 per share for a total of HK$12,541,400 on June 16, 2026.
Related Articles
HK Stock
On June 16, HANXBIO-B (03378) spent 320,500 Hong Kong dollars to repurchase 11,900 shares.
HK Stock
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
HK Stock
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
On June 16, HANXBIO-B (03378) spent 320,500 Hong Kong dollars to repurchase 11,900 shares.
HK Stock
CSPC PHARMA (01093): The application for the listing permit of Valsartan and Amlodipine Maleate Tablets (SYH 9056 Tablets) has been accepted by the National Medical Products Administration.
HK Stock
REGENT PACIFIC(00575): Senstend receives a milestone approval from the National Medical Products Administration.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.